COVID-19 Outbreak-Global Parkinson Disease Drug Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

November 2020 | 110 pages | ID: C3D08A0F1B85EN
Maia Research

Abstracts

The Parkinson Disease Drug market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Parkinson Disease Drug industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Parkinson Disease Drug market can be split based on product types, major applications, and important countries as follows:

Key players in the global Parkinson Disease Drug market covered in Chapter 12:

Sanofi S.A.
C.H. Boehringer Sohn AG & Ko. KG
ACADIA Pharmaceuticals Inc.
Homann-La Roche Ltd
Pzer, Inc.
Vertical Pharmaceuticals, LLC
Teva Pharmaceutical Industries Ltd.
UCB S.A
Medtronic plc
Orion Pharma
Merck & Co., Inc.
Novartis AG
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Lundbeck A/S
Impax Laboratories, Inc.
Abbvie Inc

In Chapter 4 and 14.1, on the basis of types, the Parkinson Disease Drug market from 2015 to 2025 is primarily split into:

Decarboxylase Inhibitors
Dopamine Agonists
Monoamine Oxidase Type B (MAO-B) Inhibitor
Catechol-O-Methyltransferase (COMT) Inhibitors
Others

In Chapter 5 and 14.2, on the basis of applications, the Parkinson Disease Drug market from 2015 to 2025 covers:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Contents

1 PARKINSON DISEASE DRUG INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Overview of Parkinson Disease Drug
1.3 Scope of The Study
  1.3.1 Key Market Segments
  1.3.2 Players Covered
  1.3.3 COVID-19's impact on the Parkinson Disease Drug industry
1.4 Methodology of The Study
1.5 Research Data Source

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Parkinson Disease Drug Market Size, 2015 – 2020
  2.1.2 Global Parkinson Disease Drug Market Size by Type, 2015 – 2020
  2.1.3 Global Parkinson Disease Drug Market Size by Application, 2015 – 2020
  2.1.4 Global Parkinson Disease Drug Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
  2.2.1 Global COVID-19 Status and Economic Overview
  2.2.2 Influence of COVID-19 Outbreak on Parkinson Disease Drug Industry Development

3 INDUSTRY CHAIN ANALYSIS

3.1 Upstream Raw Material Suppliers of Parkinson Disease Drug Analysis
3.2 Major Players of Parkinson Disease Drug
3.3 Parkinson Disease Drug Manufacturing Cost Structure Analysis
  3.3.1 Production Process Analysis
  3.3.2 Manufacturing Cost Structure of Parkinson Disease Drug
  3.3.3 Labor Cost of Parkinson Disease Drug
3.4 Market Distributors of Parkinson Disease Drug
3.5 Major Downstream Buyers of Parkinson Disease Drug Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 GLOBAL PARKINSON DISEASE DRUG MARKET, BY TYPE

4.1 Global Parkinson Disease Drug Value and Market Share by Type (2015-2020)
4.2 Global Parkinson Disease Drug Production and Market Share by Type (2015-2020)
4.3 Global Parkinson Disease Drug Value and Growth Rate by Type (2015-2020)
  4.3.1 Global Parkinson Disease Drug Value and Growth Rate of Decarboxylase Inhibitors
  4.3.2 Global Parkinson Disease Drug Value and Growth Rate of Dopamine Agonists
  4.3.3 Global Parkinson Disease Drug Value and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor
  4.3.4 Global Parkinson Disease Drug Value and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors
  4.3.5 Global Parkinson Disease Drug Value and Growth Rate of Others
4.4 Global Parkinson Disease Drug Price Analysis by Type (2015-2020)

5 PARKINSON DISEASE DRUG MARKET, BY APPLICATION

5.1 Downstream Market Overview
5.2 Global Parkinson Disease Drug Consumption and Market Share by Application (2015-2020)
5.3 Global Parkinson Disease Drug Consumption and Growth Rate by Application (2015-2020)
  5.3.1 Global Parkinson Disease Drug Consumption and Growth Rate of Hospital Pharmacy (2015-2020)
  5.3.2 Global Parkinson Disease Drug Consumption and Growth Rate of Retail Pharmacy (2015-2020)
  5.3.3 Global Parkinson Disease Drug Consumption and Growth Rate of Online Pharmacy (2015-2020)

6 GLOBAL PARKINSON DISEASE DRUG MARKET ANALYSIS BY REGIONS

6.1 Global Parkinson Disease Drug Sales, Revenue and Market Share by Regions
  6.1.1 Global Parkinson Disease Drug Sales by Regions (2015-2020)
  6.1.2 Global Parkinson Disease Drug Revenue by Regions (2015-2020)
6.2 North America Parkinson Disease Drug Sales and Growth Rate (2015-2020)
6.3 Europe Parkinson Disease Drug Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Parkinson Disease Drug Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Parkinson Disease Drug Sales and Growth Rate (2015-2020)
6.6 South America Parkinson Disease Drug Sales and Growth Rate (2015-2020)

7 NORTH AMERICA PARKINSON DISEASE DRUG MARKET ANALYSIS BY COUNTRIES

7.1 The Influence of COVID-19 on North America Market
7.2 North America Parkinson Disease Drug Sales, Revenue and Market Share by Countries
  7.2.1 North America Parkinson Disease Drug Sales by Countries (2015-2020)
  7.2.2 North America Parkinson Disease Drug Revenue by Countries (2015-2020)
7.3 United States Parkinson Disease Drug Sales and Growth Rate (2015-2020)
7.4 Canada Parkinson Disease Drug Sales and Growth Rate (2015-2020)
7.5 Mexico Parkinson Disease Drug Sales and Growth Rate (2015-2020)

8 EUROPE PARKINSON DISEASE DRUG MARKET ANALYSIS BY COUNTRIES

8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Parkinson Disease Drug Sales, Revenue and Market Share by Countries
  8.2.1 Europe Parkinson Disease Drug Sales by Countries (2015-2020)
  8.2.2 Europe Parkinson Disease Drug Revenue by Countries (2015-2020)
8.3 Germany Parkinson Disease Drug Sales and Growth Rate (2015-2020)
8.4 UK Parkinson Disease Drug Sales and Growth Rate (2015-2020)
8.5 France Parkinson Disease Drug Sales and Growth Rate (2015-2020)
8.6 Italy Parkinson Disease Drug Sales and Growth Rate (2015-2020)
8.7 Spain Parkinson Disease Drug Sales and Growth Rate (2015-2020)
8.8 Russia Parkinson Disease Drug Sales and Growth Rate (2015-2020)

9 ASIA PACIFIC PARKINSON DISEASE DRUG MARKET ANALYSIS BY COUNTRIES

9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Parkinson Disease Drug Sales, Revenue and Market Share by Countries
  9.2.1 Asia Pacific Parkinson Disease Drug Sales by Countries (2015-2020)
  9.2.2 Asia Pacific Parkinson Disease Drug Revenue by Countries (2015-2020)
9.3 China Parkinson Disease Drug Sales and Growth Rate (2015-2020)
9.4 Japan Parkinson Disease Drug Sales and Growth Rate (2015-2020)
9.5 South Korea Parkinson Disease Drug Sales and Growth Rate (2015-2020)
9.6 India Parkinson Disease Drug Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Parkinson Disease Drug Sales and Growth Rate (2015-2020)
9.8 Australia Parkinson Disease Drug Sales and Growth Rate (2015-2020)

10 MIDDLE EAST AND AFRICA PARKINSON DISEASE DRUG MARKET ANALYSIS BY COUNTRIES

10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Parkinson Disease Drug Sales, Revenue and Market Share by Countries
  10.2.1 Middle East and Africa Parkinson Disease Drug Sales by Countries (2015-2020)
  10.2.2 Middle East and Africa Parkinson Disease Drug Revenue by Countries (2015-2020)
10.3 Saudi Arabia Parkinson Disease Drug Sales and Growth Rate (2015-2020)
10.4 UAE Parkinson Disease Drug Sales and Growth Rate (2015-2020)
10.5 Egypt Parkinson Disease Drug Sales and Growth Rate (2015-2020)
10.6 Nigeria Parkinson Disease Drug Sales and Growth Rate (2015-2020)
10.7 South Africa Parkinson Disease Drug Sales and Growth Rate (2015-2020)

11 SOUTH AMERICA PARKINSON DISEASE DRUG MARKET ANALYSIS BY COUNTRIES

11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Parkinson Disease Drug Sales, Revenue and Market Share by Countries
  11.2.1 South America Parkinson Disease Drug Sales by Countries (2015-2020)
  11.2.2 South America Parkinson Disease Drug Revenue by Countries (2015-2020)
11.3 Brazil Parkinson Disease Drug Sales and Growth Rate (2015-2020)
11.4 Argentina Parkinson Disease Drug Sales and Growth Rate (2015-2020)
11.5 Columbia Parkinson Disease Drug Sales and Growth Rate (2015-2020)
11.6 Chile Parkinson Disease Drug Sales and Growth Rate (2015-2020)

12 COMPETITIVE LANDSCAPE

12.1 Sanofi S.A.
  12.1.1 Sanofi S.A. Basic Information
  12.1.2 Parkinson Disease Drug Product Introduction
  12.1.3 Sanofi S.A. Production, Value, Price, Gross Margin 2015-2020
12.2 C.H. Boehringer Sohn AG & Ko. KG
  12.2.1 C.H. Boehringer Sohn AG & Ko. KG Basic Information
  12.2.2 Parkinson Disease Drug Product Introduction
  12.2.3 C.H. Boehringer Sohn AG & Ko. KG Production, Value, Price, Gross Margin 2015-2020
12.3 ACADIA Pharmaceuticals Inc.
  12.3.1 ACADIA Pharmaceuticals Inc. Basic Information
  12.3.2 Parkinson Disease Drug Product Introduction
  12.3.3 ACADIA Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
12.4 Homann-La Roche Ltd
  12.4.1 Homann-La Roche Ltd Basic Information
  12.4.2 Parkinson Disease Drug Product Introduction
  12.4.3 Homann-La Roche Ltd Production, Value, Price, Gross Margin 2015-2020
12.5 Pzer, Inc.
  12.5.1 Pzer, Inc. Basic Information
  12.5.2 Parkinson Disease Drug Product Introduction
  12.5.3 Pzer, Inc. Production, Value, Price, Gross Margin 2015-2020
12.6 Vertical Pharmaceuticals, LLC
  12.6.1 Vertical Pharmaceuticals, LLC Basic Information
  12.6.2 Parkinson Disease Drug Product Introduction
  12.6.3 Vertical Pharmaceuticals, LLC Production, Value, Price, Gross Margin 2015-2020
12.7 Teva Pharmaceutical Industries Ltd.
  12.7.1 Teva Pharmaceutical Industries Ltd. Basic Information
  12.7.2 Parkinson Disease Drug Product Introduction
  12.7.3 Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2015-2020
12.8 UCB S.A
  12.8.1 UCB S.A Basic Information
  12.8.2 Parkinson Disease Drug Product Introduction
  12.8.3 UCB S.A Production, Value, Price, Gross Margin 2015-2020
12.9 Medtronic plc
  12.9.1 Medtronic plc Basic Information
  12.9.2 Parkinson Disease Drug Product Introduction
  12.9.3 Medtronic plc Production, Value, Price, Gross Margin 2015-2020
12.10 Orion Pharma
  12.10.1 Orion Pharma Basic Information
  12.10.2 Parkinson Disease Drug Product Introduction
  12.10.3 Orion Pharma Production, Value, Price, Gross Margin 2015-2020
12.11 Merck & Co., Inc.
  12.11.1 Merck & Co., Inc. Basic Information
  12.11.2 Parkinson Disease Drug Product Introduction
  12.11.3 Merck & Co., Inc. Production, Value, Price, Gross Margin 2015-2020
12.12 Novartis AG
  12.12.1 Novartis AG Basic Information
  12.12.2 Parkinson Disease Drug Product Introduction
  12.12.3 Novartis AG Production, Value, Price, Gross Margin 2015-2020
12.13 F. Hoffmann-La Roche AG
  12.13.1 F. Hoffmann-La Roche AG Basic Information
  12.13.2 Parkinson Disease Drug Product Introduction
  12.13.3 F. Hoffmann-La Roche AG Production, Value, Price, Gross Margin 2015-2020
12.14 GlaxoSmithKline plc
  12.14.1 GlaxoSmithKline plc Basic Information
  12.14.2 Parkinson Disease Drug Product Introduction
  12.14.3 GlaxoSmithKline plc Production, Value, Price, Gross Margin 2015-2020
12.15 Lundbeck A/S
  12.15.1 Lundbeck A/S Basic Information
  12.15.2 Parkinson Disease Drug Product Introduction
  12.15.3 Lundbeck A/S Production, Value, Price, Gross Margin 2015-2020
12.16 Impax Laboratories, Inc.
  12.16.1 Impax Laboratories, Inc. Basic Information
  12.16.2 Parkinson Disease Drug Product Introduction
  12.16.3 Impax Laboratories, Inc. Production, Value, Price, Gross Margin 2015-2020
12.17 Abbvie Inc
  12.17.1 Abbvie Inc Basic Information
  12.17.2 Parkinson Disease Drug Product Introduction
  12.17.3 Abbvie Inc Production, Value, Price, Gross Margin 2015-2020

13 INDUSTRY OUTLOOK

13.1 Market Driver Analysis
  13.1.2 Market Restraints Analysis
  13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 GLOBAL PARKINSON DISEASE DRUG MARKET FORECAST

14.1 Global Parkinson Disease Drug Market Value & Volume Forecast, by Type (2020-2025)
  14.1.1 Decarboxylase Inhibitors Market Value and Volume Forecast (2020-2025)
  14.1.2 Dopamine Agonists Market Value and Volume Forecast (2020-2025)
  14.1.3 Monoamine Oxidase Type B (MAO-B) Inhibitor Market Value and Volume Forecast (2020-2025)
  14.1.4 Catechol-O-Methyltransferase (COMT) Inhibitors Market Value and Volume Forecast (2020-2025)
  14.1.5 Others Market Value and Volume Forecast (2020-2025)
14.2 Global Parkinson Disease Drug Market Value & Volume Forecast, by Application (2020-2025)
  14.2.1 Hospital Pharmacy Market Value and Volume Forecast (2020-2025)
  14.2.2 Retail Pharmacy Market Value and Volume Forecast (2020-2025)
  14.2.3 Online Pharmacy Market Value and Volume Forecast (2020-2025)
14.3 Parkinson Disease Drug Market Analysis and Forecast by Region
  14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 NEW PROJECT FEASIBILITY ANALYSIS

15.1 Industry Barriers and New Entrants SWOT Analysis
  15.1.1 Porter’s Five Forces Analysis
  15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Parkinson Disease Drug
Table Product Specification of Parkinson Disease Drug
Table Parkinson Disease Drug Key Market Segments
Table Key Players Parkinson Disease Drug Covered
Figure Global Parkinson Disease Drug Market Size, 2015 – 2025
Table Different Types of Parkinson Disease Drug
Figure Global Parkinson Disease Drug Value ($) Segment by Type from 2015-2020
Figure Global Parkinson Disease Drug Market Share by Types in 2019
Table Different Applications of Parkinson Disease Drug
Figure Global Parkinson Disease Drug Value ($) Segment by Applications from 2015-2020
Figure Global Parkinson Disease Drug Market Share by Applications in 2019
Figure Global Parkinson Disease Drug Market Share by Regions in 2019
Figure North America Parkinson Disease Drug Production Value ($) and Growth Rate (2015-2020)
Figure Europe Parkinson Disease Drug Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Parkinson Disease Drug Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Parkinson Disease Drug Production Value ($) and Growth Rate (2015-2020)
Figure South America Parkinson Disease Drug Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Parkinson Disease Drug
Table Upstream Raw Material Suppliers of Parkinson Disease Drug with Contact Information
Table Major Players Headquarters, and Service Area of Parkinson Disease Drug
Figure Major Players Production Value Market Share of Parkinson Disease Drug in 2019
Table Major Players Parkinson Disease Drug Product Types in 2019
Figure Production Process of Parkinson Disease Drug
Figure Manufacturing Cost Structure of Parkinson Disease Drug
Figure Channel Status of Parkinson Disease Drug
Table Major Distributors of Parkinson Disease Drug with Contact Information
Table Major Downstream Buyers of Parkinson Disease Drug with Contact Information
Table Global Parkinson Disease Drug Value ($) by Type (2015-2020)
Table Global Parkinson Disease Drug Value Share by Type (2015-2020)
Figure Global Parkinson Disease Drug Value Share by Type (2015-2020)
Table Global Parkinson Disease Drug Production by Type (2015-2020)
Table Global Parkinson Disease Drug Production Share by Type (2015-2020)
Figure Global Parkinson Disease Drug Production Share by Type (2015-2020)
Figure Global Parkinson Disease Drug Value ($) and Growth Rate of Decarboxylase Inhibitors (2015-2020)
Figure Global Parkinson Disease Drug Value ($) and Growth Rate of Dopamine Agonists (2015-2020)
Figure Global Parkinson Disease Drug Value ($) and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2015-2020)
Figure Global Parkinson Disease Drug Value ($) and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2015-2020)
Figure Global Parkinson Disease Drug Value ($) and Growth Rate of Others (2015-2020)
Figure Global Parkinson Disease Drug Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Parkinson Disease Drug Consumption by Application (2015-2020)
Table Global Parkinson Disease Drug Consumption Market Share by Application (2015-2020)
Figure Global Parkinson Disease Drug Consumption Market Share by Application (2015-2020)
Figure Global Parkinson Disease Drug Consumption and Growth Rate of Hospital Pharmacy (2015-2020)
Figure Global Parkinson Disease Drug Consumption and Growth Rate of Retail Pharmacy (2015-2020)
Figure Global Parkinson Disease Drug Consumption and Growth Rate of Online Pharmacy (2015-2020)
Figure Global Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Global Parkinson Disease Drug Revenue (M USD) and Growth (2015-2020)
Table Global Parkinson Disease Drug Sales by Regions (2015-2020)
Table Global Parkinson Disease Drug Sales Market Share by Regions (2015-2020)
Table Global Parkinson Disease Drug Revenue (M USD) by Regions (2015-2020)
Table Global Parkinson Disease Drug Revenue Market Share by Regions (2015-2020)
Table Global Parkinson Disease Drug Revenue Market Share by Regions in 2015
Table Global Parkinson Disease Drug Revenue Market Share by Regions in 2019
Figure North America Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Europe Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure South America Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Parkinson Disease Drug Revenue (M USD) and Growth (2015-2020)
Table North America Parkinson Disease Drug Sales by Countries (2015-2020)
Table North America Parkinson Disease Drug Sales Market Share by Countries (2015-2020)
Table North America Parkinson Disease Drug Revenue (M USD) by Countries (2015-2020)
Table North America Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure United States Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Canada Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Mexico Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Parkinson Disease Drug Revenue (M USD) and Growth (2015-2020)
Table Europe Parkinson Disease Drug Sales by Countries (2015-2020)
Table Europe Parkinson Disease Drug Sales Market Share by Countries (2015-2020)
Table Europe Parkinson Disease Drug Revenue (M USD) by Countries (2015-2020)
Table Europe Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure Germany Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure UK Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure France Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Italy Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Spain Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Russia Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Parkinson Disease Drug Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Parkinson Disease Drug Sales by Countries (2015-2020)
Table Asia Pacific Parkinson Disease Drug Sales Market Share by Countries (2015-2020)
Table Asia Pacific Parkinson Disease Drug Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure China Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Japan Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure South Korea Parkinson Disease Drug Sales and Growth (2015-2020)
Figure India Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Southeast Asia Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Australia Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Middle East Parkinson Disease Drug Revenue (M USD) and Growth (2015-2020)
Table Middle East Parkinson Disease Drug Sales by Countries (2015-2020)
Table Middle East and Africa Parkinson Disease Drug Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Parkinson Disease Drug Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure UAE Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Egypt Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Nigeria Parkinson Disease Drug Sales and Growth (2015-2020)
Figure South Africa Parkinson Disease Drug Sales and Growth (2015-2020)
Figure South America Parkinson Disease Drug Revenue (M USD) and Growth (2015-2020)
Table South America Parkinson Disease Drug Sales by Countries (2015-2020)
Table South America Parkinson Disease Drug Sales Market Share by Countries (2015-2020)
Table South America Parkinson Disease Drug Revenue (M USD) by Countries (2015-2020)
Table South America Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure Brazil Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Argentina Parkinson Disease Drug Sales and Growth Rate (2015-2020)
Figure Columbia Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Chile Parkinson Disease Drug Sales and Growth (2015-2020)
Figure Top 3 Market Share of Parkinson Disease Drug Companies in 2019
Figure Top 6 Market Share of Parkinson Disease Drug Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Sanofi S.A. Profile
Table Sanofi S.A. Product Introduction
Figure Sanofi S.A. Production and Growth Rate
Figure Sanofi S.A. Value ($) Market Share 2015-2020
Table C.H. Boehringer Sohn AG & Ko. KG Profile
Table C.H. Boehringer Sohn AG & Ko. KG Product Introduction
Figure C.H. Boehringer Sohn AG & Ko. KG Production and Growth Rate
Figure C.H. Boehringer Sohn AG & Ko. KG Value ($) Market Share 2015-2020
Table ACADIA Pharmaceuticals Inc. Profile
Table ACADIA Pharmaceuticals Inc. Product Introduction
Figure ACADIA Pharmaceuticals Inc. Production and Growth Rate
Figure ACADIA Pharmaceuticals Inc. Value ($) Market Share 2015-2020
Table Homann-La Roche Ltd Profile
Table Homann-La Roche Ltd Product Introduction
Figure Homann-La Roche Ltd Production and Growth Rate
Figure Homann-La Roche Ltd Value ($) Market Share 2015-2020
Table Pzer, Inc. Profile
Table Pzer, Inc. Product Introduction
Figure Pzer, Inc. Production and Growth Rate
Figure Pzer, Inc. Value ($) Market Share 2015-2020
Table Vertical Pharmaceuticals, LLC Profile
Table Vertical Pharmaceuticals, LLC Product Introduction
Figure Vertical Pharmaceuticals, LLC Production and Growth Rate
Figure Vertical Pharmaceuticals, LLC Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Product Introduction
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2015-2020
Table UCB S.A Profile
Table UCB S.A Product Introduction
Figure UCB S.A Production and Growth Rate
Figure UCB S.A Value ($) Market Share 2015-2020
Table Medtronic plc Profile
Table Medtronic plc Product Introduction
Figure Medtronic plc Production and Growth Rate
Figure Medtronic plc Value ($) Market Share 2015-2020
Table Orion Pharma Profile
Table Orion Pharma Product Introduction
Figure Orion Pharma Production and Growth Rate
Figure Orion Pharma Value ($) Market Share 2015-2020
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Product Introduction
Figure Merck & Co., Inc. Production and Growth Rate
Figure Merck & Co., Inc. Value ($) Market Share 2015-2020
Table Novartis AG Profile
Table Novartis AG Product Introduction
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Product Introduction
Figure F. Hoffmann-La Roche AG Production and Growth Rate
Figure F. Hoffmann-La Roche AG Value ($) Market Share 2015-2020
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Product Introduction
Figure GlaxoSmithKline plc Production and Growth Rate
Figure GlaxoSmithKline plc Value ($) Market Share 2015-2020
Table Lundbeck A/S Profile
Table Lundbeck A/S Product Introduction
Figure Lundbeck A/S Production and Growth Rate
Figure Lundbeck A/S Value ($) Market Share 2015-2020
Table Impax Laboratories, Inc. Profile
Table Impax Laboratories, Inc. Product Introduction
Figure Impax Laboratories, Inc. Production and Growth Rate
Figure Impax Laboratories, Inc. Value ($) Market Share 2015-2020
Table Abbvie Inc Profile
Table Abbvie Inc Product Introduction
Figure Abbvie Inc Production and Growth Rate
Figure Abbvie Inc Value ($) Market Share 2015-2020
Table Market Driving Factors of Parkinson Disease Drug
Table Merger, Acquisition and New Investment
Table Global Parkinson Disease Drug Market Value ($) Forecast, by Type
Table Global Parkinson Disease Drug Market Volume Forecast, by Type
Figure Global Parkinson Disease Drug Market Value ($) and Growth Rate Forecast of Decarboxylase Inhibitors (2020-2025)
Figure Global Parkinson Disease Drug Market Volume ($) and Growth Rate Forecast of Decarboxylase Inhibitors (2020-2025)
Figure Global Parkinson Disease Drug Market Value ($) and Growth Rate Forecast of Dopamine Agonists (2020-2025)
Figure Global Parkinson Disease Drug Market Volume ($) and Growth Rate Forecast of Dopamine Agonists (2020-2025)
Figure Global Parkinson Disease Drug Market Value ($) and Growth Rate Forecast of Monoamine Oxidase Type B (MAO-B) Inhibitor (2020-2025)
Figure Global Parkinson Disease Drug Market Volume ($) and Growth Rate Forecast of Monoamine Oxidase Type B (MAO-B) Inhibitor (2020-2025)
Figure Global Parkinson Disease Drug Market Value ($) and Growth Rate Forecast of Catechol-O-Methyltransferase (COMT) Inhibitors (2020-2025)
Figure Global Parkinson Disease Drug Market Volume ($) and Growth Rate Forecast of Catechol-O-Methyltransferase (COMT) Inhibitors (2020-2025)
Figure Global Parkinson Disease Drug Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Parkinson Disease Drug Market Volume ($) and Growth Rate Forecast of Others (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospital Pharmacy (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospital Pharmacy (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Retail Pharmacy (2020-2025)
Figure Market Volume and Growth Rate Forecast of Retail Pharmacy (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Online Pharmacy (2020-2025)
Figure Market Volume and Growth Rate Forecast of Online Pharmacy (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery